Dun & Bradstreet [DNB] vs CME [CME] Detailed Stock Comparison

Dun & Bradstreet

NYSE
Loading...

CME

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Dun & Bradstreet wins in 6 metrics, CME wins in 13 metrics, with 0 ties. CME appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricDun & BradstreetCMEBetter
P/E Ratio (TTM)-130.7125.62Dun & Bradstreet
Price-to-Book Ratio1.233.43Dun & Bradstreet
Debt-to-Equity Ratio106.7613.60CME
PEG Ratio-1.311.64Dun & Bradstreet
EV/EBITDA12.0221.35Dun & Bradstreet
Profit Margin (TTM)-1.60%58.59%CME
Operating Margin (TTM)3.54%66.87%CME
EBITDA Margin (TTM)3.54%66.87%CME
Return on Equity-1.03%13.61%CME
Return on Assets (TTM)1.60%1.74%CME
Free Cash Flow (TTM)$223.00M$3.60BCME
Dividend YieldN/A4.30%N/A
1-Year Return-23.75%18.89%CME
Price-to-Sales Ratio (TTM)1.7014.83Dun & Bradstreet
Enterprise Value$7.37B$97.06BCME
EV/Revenue Ratio3.0615.09Dun & Bradstreet
Gross Profit Margin (TTM)58.58%86.90%CME
Revenue per Share (TTM)$6$18CME
Earnings per Share (Diluted)$-0.09$10.33CME
Beta (Stock Volatility)1.120.43CME
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Dun & Bradstreet vs CME Stock Performance Analysis

Loading Price Chart...

Dun & Bradstreet
CME
Dun & Bradstreet Stock Overview | CME Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Dun & Bradstreet0.44%0.55%0.33%1.67%0.44%-25.91%
CME0.59%-2.44%0.39%-6.71%4.45%13.27%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Dun & Bradstreet-23.75%-35.38%-62.90%-66.24%-66.24%-66.24%
CME18.89%53.42%56.91%193.21%392.71%315.51%

News Based Sentiment: Dun & Bradstreet vs CME

Dun & Bradstreet

News based Sentiment: MIXED

September marked a pivotal shift for Dun & Bradstreet with the completion of its acquisition, a new CEO appointment, and continued financial struggles. While the acquisition provides a fresh start, the Q2 earnings miss and mixed investor activity create uncertainty, resulting in a 'mixed' sentiment and a high importance score due to the scale of the changes.

View Dun & Bradstreet News Sentiment Analysis

CME

News based Sentiment: POSITIVE

CME Group is showing strong performance in both its traditional markets and its expanding cryptocurrency offerings. Analyst upgrades, insider buying, and record trading volumes in crypto all contribute to a positive outlook, making this a significant month for the company.

View CME News Sentiment Analysis

Performance & Financial Health Analysis: Dun & Bradstreet vs CME

MetricDNBCME
Market Information
Market Cap i$4.08B$96.97B
Market Cap CategoryMid capLarge cap
10 Day Avg. Volume i5,208,2391,751,020
90 Day Avg. Volume i3,454,5861,905,747
Last Close$9.15$263.60
52 Week Range$7.78 - $12.94$213.94 - $290.79
% from 52W High-29.32%-9.35%
All-Time High$29.55 (Nov 02, 2020)$290.79 (Jun 02, 2025)
% from All-Time High-69.04%-9.35%
Growth Metrics
Quarterly Revenue Growth0.02%0.10%
Quarterly Earnings Growth0.02%0.16%
Financial Health
Profit Margin (TTM) i-0.02%0.59%
Operating Margin (TTM) i0.04%0.67%
Return on Equity (TTM) i-0.01%0.14%
Debt to Equity (MRQ) i106.7613.60
Cash & Liquidity
Book Value per Share (MRQ)$7.41$77.13
Cash per Share (MRQ)$0.64$5.82
Operating Cash Flow (TTM) i$454.50M$4.20B
Levered Free Cash Flow (TTM) i$593.36M$2.92B
Dividends
Last 12-Month Dividend Yield iN/A4.30%
Last 12-Month Dividend iN/A$11.85

Valuation & Enterprise Metrics Analysis: Dun & Bradstreet vs CME

MetricDNBCME
Price Ratios
P/E Ratio (TTM) i-130.7125.62
Forward P/E i8.2425.52
PEG Ratio i-1.311.64
Price to Sales (TTM) i1.7014.83
Price to Book (MRQ) i1.233.43
Market Capitalization
Market Capitalization i$4.08B$96.97B
Enterprise Value i$7.37B$97.06B
Enterprise Value Metrics
Enterprise to Revenue i3.0615.09
Enterprise to EBITDA i12.0221.35
Risk & Other Metrics
Beta i1.120.43
Book Value per Share (MRQ) i$7.41$77.13

Financial Statements Comparison: Dun & Bradstreet vs CME

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)DNBCME
Revenue/Sales i$579.80M$1.64B
Cost of Goods Sold i$227.80M$206.70M
Gross Profit i$352.00M$1.44B
Research & Development iN/AN/A
Operating Income (EBIT) i$38.20M$1.11B
EBITDA i$185.70M$476.30M
Pre-Tax Income i$-14.80M$1.24B
Income Tax i$400,000$288.60M
Net Income (Profit) i$-14.80M$956.20M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)DNBCME
Cash & Equivalents i$241.30M$1.41B
Total Current Assets i$650.40M$123.45B
Total Current Liabilities i$1.05B$121.42B
Long-Term Debt i$3.53B$3.42B
Total Shareholders Equity i$3.31B$27.03B
Retained Earnings i$-855.50M$4.69B
Property, Plant & Equipment i$187.80M$371.20M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)DNBCME
Operating Cash Flow i$228.10M$838.30M
Capital Expenditures iN/A$-14.20M
Free Cash Flow i$90.20M$1.10B
Debt Repayment i$-67.80M$-750.00M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricDNBCME
Shares Short i17.88M4.63M
Short Ratio i6.532.42
Short % of Float i0.05%0.01%
Average Daily Volume (10 Day) i5,208,2391,751,020
Average Daily Volume (90 Day) i3,454,5861,905,747
Shares Outstanding i441.55M359.61M
Float Shares i315.39M358.80M
% Held by Insiders i0.09%0.00%
% Held by Institutions i0.90%0.92%

Dividend Analysis & Yield Comparison: Dun & Bradstreet vs CME

MetricDNBCME
Last 12-Month Dividend iN/A$11.85
Last 12-Month Dividend Yield iN/A4.30%
3-Year Avg Annual Dividend iN/A$10.10
3-Year Avg Dividend Yield iN/A0.91%
3-Year Total Dividends iN/A$30.30
Ex-Dividend DateN/ASep 09, 2025